However, PR3/AAT ratio was significantly lower in patients with type 2 diabetes when compared to patients with liver steatosis (p < 0.0001) (Fig. 1d) suggesting a potential specific association of PR3 with liver steatosis. This evidence concerns the gene SERPINA1 and fatty liver disease.